Zedsen Limited

Zedsen Limited

Zedsen is on a mission to pioneer transformative digital healthcare sensors to engage the world in proactive wellness and save a million lives.

From non-invasively monitoring levels of glucose in the blood, to identifying tumours in the breast, we are shifting the paradigm from curative to preventative care.

Zedsen’s patented technology creates a 3-Dimensional Multiplexing Electric Field Sensing technique (MEFS), which identifies the electrical properties of any substance or material within the electrical field created by the sensor.

When biological tissue is situated within this layered electric field, the changes in terms of direction and magnitude are quantified to define specific electrical properties of the tissue. The sensor does not impact or change the parameters of the tissue, ensuring highly accurate measurements.

Zedsen’s bespoke measurement algorithms, such as variable voltage, patented dynamic grounding and multi-strobing, combined with advanced machine learning techniques allows for in-depth tissue analysis at varying depths.

These award-winning 3D sensors are non-invasive, non-radiating and have no negative effect on biological tissue. The technology is inherently low cost, paper-thin, flexible and can interconnect with an infinite number of devices.

ADVISORY COUNCIL NOMINEE

Daniel Honeywell

Daniel Honeywell

CEO

Zedsen Limited